New Enterprises Limited v. SenesTech Incorporated et al
Filing
82
ORDER denying Defendant Roth Capital Partners, LLC's 70 Motion to Dismiss; denying Defendant SenesTech, Inc.'s 71 Motion to Dismiss. See attachment for details. Signed by Senior Judge James A Teilborg on 8/16/19. (CLB)
1
WO
2
3
4
5
6
IN THE UNITED STATES DISTRICT COURT
7
FOR THE DISTRICT OF ARIZONA
8
9
New Enterprises Limited,
Plaintiff,
10
11
ORDER
v.
12
No. CV-18-08033-PCT-JAT
SenesTech Incorporated, et al.,
13
Defendants.
14
15
Pending before the Court are Defendant SenesTech, Inc.’s (“Defendant
16
SenesTech”) Motion to Dismiss (Doc. 71) and Defendant Roth Capital Partners, LLC’s
17
(“Defendant Roth”) Motion to Dismiss (Doc. 70) pursuant to Federal Rules of Civil
18
Procedure (“Rules”) 8(a), 9(b), and 12(b)(6). The Court now rules on the motions.
19
I.
BACKGROUND
20
The Court previously dismissed Plaintiff New Enterprises, Ltd.’s (“Plaintiff”)
21
original Complaint (“OC,” Doc. 1), finding that Plaintiff failed to state a claim upon which
22
relief could be granted. (See Doc. 57). Specifically, the Court found that Plaintiff both
23
failed to adequately plead fraud with particularity, because it did not state the “who, what,
24
when, where, and how” of allegedly fraudulent misrepresentations, and failed to plead an
25
essential element of its other claims. (See Doc. 57 at 7, 13 (citation omitted)). Plaintiff then
26
amended the OC, and Defendants now seek to dismiss Plaintiff’s First Amended Complaint
27
(“FAC,” Doc. 69).
28
On April 18, 2019, Defendant SenesTech filed its Motion to Dismiss (Doc. 71).
1
Plaintiff filed a Response (Doc. 73) on May 2, 2019, and Defendant SenesTech then filed
2
a Reply (Doc. 74) on May 9, 2019. On April 18, 2019, Defendant Roth also filed its Motion
3
to Dismiss (Doc. 70). Plaintiff filed a Response (Doc. 72) on May 2, 2019, and Defendant
4
Roth filed a Reply (Doc. 75) on May 9, 2019.
5
The eight-count FAC (Doc. 69) asserts the following causes of action discussed
6
herein: (I) common law fraud; (II) federal securities fraud; (III) state securities fraud
7
(Arizona); (IV) violation of Delaware Code § 8-401; (V) breach of contract; (VI) tortious
8
interference with a prospective business advantage; (VII) conversion; and (VIII) breach of
9
contract. (FAC ¶¶ 71–139).1 Plaintiff asserts counts (I)–(V) against only Defendant
10
SenesTech, counts (VI)–(VII) against both Defendant SenesTech and Defendant Roth
11
(collectively, “Defendants”), and count (VIII) against only Defendant Roth. (Id.).
12
A.
13
The following facts are either undisputed or recounted in the light most favorable to
14
the non-moving party. See Wyler Summit P’ship v. Turner Broad. Sys., Inc., 135 F.3d 658,
15
661 (9th Cir. 1998). Defendant SenesTech, a Delaware corporation, is a public company
16
that sells a rodent-control solution that causes infertility in rats. (FAC at ¶ 7). Plaintiff is a
17
privately held family investment trust incorporated in the British Virgin Islands with its
18
principal place of business in Singapore. (Id. at ¶¶ 1–6). At times, Plaintiff acted through
19
its agent, Subbiah Subramanian. (Id. at ¶ 6). Defendant Roth is a California-based
20
investment banking firm that acted as the underwriter for Defendant SenesTech’s initial
21
public offering (the “IPO”). (Id. at ¶ 8).
22
Facts
1.
Negotiations and Loans
23
In March 2015, Defendant SenesTech’s then-CEO, Thomas Ziemba, engaged
24
Plaintiff—through Subramanian as its agent—in negotiations for capital. (Id. at ¶ 12).
25
Plaintiff alleges Ziemba orally represented to Subramanian at an in-person meeting in
26
27
28
1
The Court observes that Plaintiff removed one count (originally, count (II)
common law fraud) from the OC and reduced the number of claims brought against both
Defendants in the FAC. (Compare OC at ¶¶ 53–107, with FAC at ¶¶ 71–139). Plaintiff
largely realleges the same facts discussed in the OC, but also adds additional facts in the
FAC. (See Doc. 60-2).
-2-
1
Fremont, California that Defendant SenesTech “was worth approximately $55 to $60
2
million.” (Id. at ¶ 13). Plaintiff also alleges Ziemba stated that the “current value of
3
[Defendant] SenesTech’s stock” was “$1.50 per share” at this meeting. (Id.).
4
Plaintiff further alleges Defendant SenesTech “commissioned Redwood Valuation
5
Partners, an independent professional appraiser,” to provide a valuation (the “Redwood
6
Valuation”) of its company in March 2015. (Id. at ¶¶ 14, 21). The Redwood Valuation
7
concluded, “as of March 9, 2015, the fair market value of the Company’s common stock
8
was $0.06 per share, consistent with a total corporate valuation of less than $2 million.”
9
(Id. at ¶¶ 14, 22). Plaintiff alleges Ziemba “was aware of the Redwood Valuation when he
10
first informed Subramanian that SenesTech had a corporate valuation of $55 million to $60
11
million, and at all subsequent times he repeated that statement.” (Id. at ¶ 23).
12
Without knowledge of the Redwood Valuation, Plaintiff made a secured loan of
13
$500,000 to Defendant SenesTech (the “April 2015 Loan”) on April 18, 2015. (Id. at 15).
14
In connection with the April 2015 Loan, Plaintiff received a warrant allowing it to purchase
15
up to 346,667 shares of common stock in Defendant SenesTech at $1.50 per share. (Id.).
16
Between September 4, 2015 and December 15, 2015, Plaintiff made a series of four
17
additional secured loans to Defendant SenesTech, totaling $500,000 (the “Late 2015
18
Loans”). (Id. ¶ 16). These loans were convertible to common or Series B preferred stock
19
in Defendant SenesTech at $1.55 per share, and executed with another stock warrant
20
permitting Plaintiff to purchase additional common stock at $1.50 per share. (Id.).
21
2.
2015 Option Awards
22
On July 3, 2015, Defendant SenesTech awarded 1,500,000 options to its founders
23
and an additional 2,528,466 options to Ziemba, all with an exercise price of $0.10 per share.
24
(Id. at ¶ 25). Defendant SenesTech continued to provide similar options grants at the $0.10
25
per share exercise price throughout the rest of 2015 (collectively, the “2015 Option
26
Awards”). (Id. ¶¶ 26–28). Plaintiff alleges Defendant SenesTech concealed these stock
27
option awards from Plaintiff during all relevant time periods, including during negotiation
28
of the Late 2015 Loans. (Id. ¶¶ 20, 29–30). The board of directors of Defendant SenesTech
-3-
1
also affirmed the validity of the Redwood Valuation when awarding options throughout
2
2015. (Id. at ¶¶ 24, 28).
3
3.
Equity Investments by Plaintiff
4
On December 31, 2015, Plaintiff agreed to convert the Late 2015 Loans into
5
333,255 shares of Series B preferred stock at $1.55 per share while still unaware of the
6
Redwood Valuation. (Id. at ¶ 32). Between April 8, 2016 and May 6, 2016, Plaintiff agreed
7
to cancel the April 2015 Loan in exchange for an additional 1,021,800 shares of common
8
stock in Defendant SenesTech at $0.50 per share. (Id. at ¶ 37). Plaintiff also purchased an
9
additional 300,000 shares at this time. (Id.). Plaintiff alleges it would not have made these
10
additional equity investments had it known of the millions of options awarded at a lower
11
exercise price of $0.10 per share or the Redwood Valuation. (Id. ¶ at 38). In September
12
2016, Defendant SenesTech approved a reverse stock split that brought Plaintiff’s total
13
holdings in Defendant SenesTech to 331,011 shares, acquired at a weighted average basis
14
of $3.45 per share. (Id. at ¶ 41). At all relevant times, all stock in Defendant SenesTech
15
owned by Plaintiff was “maintained in uncertificated ‘book entry’ form, such that no
16
physical stock certificates exist.” (Id. at ¶ 42).
17
4.
Stock Restrictions
18
All of the book entries for Plaintiff’s stock in Defendant SenesTech contained a
19
restriction “stating the securities at issue had not been registered and could not be sold or
20
otherwise transferred or assigned until either the securities became registered, or
21
[Defendant] SenesTech received a satisfactory opinion of counsel stating that such
22
registration is not required for sale or transfer.” (Id. at ¶ 43). In advance of the IPO,
23
Plaintiff’s counsel provided an opinion letter (the “November Opinion Letter”) on
24
November 7, 2016 to Defendant SenesTech stating that certain shares held by Plaintiff did
25
not require registration, so the restriction on the corresponding shares could be removed.
26
(Id. at ¶¶ 48–49). Plaintiff alleges Defendant SenesTech was “obligated to conclude that
27
the [November Opinion Letter] was a ‘satisfactory opinion of counsel[.]’” (Id. at ¶ 49).
28
Defendant SenesTech refused this request the same day by explaining that “[Defendant]
-4-
1
Roth has said they will not permit any delegending of shares at this [time].” (Id. at ¶ 51).
2
Defendant SenesTech continued to refuse to instruct its transfer agent to remove the
3
restriction from Plaintiff’s shares, allegedly blocking Plaintiff from selling its shares and
4
profiting during the IPO process. (Id. at ¶ 53).
5
5.
Lock-Up Agreement
6
Shortly thereafter, Defendant Roth proposed Plaintiff agree to a “Lock-Up
7
Agreement,” under which Plaintiff and other investors would be prohibited from selling its
8
shares in Defendant SenesTech for 180 days following the IPO without the prior written
9
consent of Defendant Roth. (Id. at ¶ 54). On or about November 13, 2016, Plaintiff agreed
10
to the Lock-Up Agreement that prohibited Plaintiff from selling its stock for 180 days post-
11
IPO. (Id. at ¶¶ at 55, 60). In exchange for Plaintiff’s acquiescence to the Lock-Up
12
Agreement, Defendant Roth agreed to exempt 50,000 shares held by Plaintiff, such that
13
Plaintiff would not have to procure prior authorization from Defendant Roth to sell any of
14
those 50,000 shares “right after the IPO[.]” (Id. at ¶ 55). Defendant SenesTech’s filing with
15
the U.S. Securities and Exchange Commission (“SEC”) stated that Defendant Roth had
16
“sole discretion” to “release for sale in the public market all or any portion of the shares
17
restricted by the terms of the lock-up agreements.” (Id. at ¶ 58 (emphasis added)).
18
6.
The IPO
19
On December 8, 2016 Defendant SenesTech held an IPO of common stock at a price
20
of $8 per share. (Id. at ¶ 62). In December 2016, Plaintiff contacted Defendant Roth to
21
secure removal of the restriction on sale for the 50,000 shares carved out of the Lock-Up
22
Agreement. (Id. at ¶ 64). Defendant Roth, however, “refused to authorize [Defendant]
23
SenesTech to remove the restriction,” thus rendering it impossible for Plaintiff to sell any
24
shares at that time. (Id.). On April 18, 2017, Plaintiff presented Defendant SenesTech with
25
a new opinion letter stating that the shares held by Plaintiff did not require registration in
26
order to be sold or transferred. (Id. at ¶ 67). On May 4, 2017, Defendant SenesTech’s
27
transfer agent reissued 50,000 shares of stock in Defendant SenesTech to Plaintiff without
28
the applicable restriction. (Id. at ¶ 68). At that point, Defendant SenesTech’s stock had
-5-
1
fallen from an all-time high of $10.68 on January 17, 2017 to $6.58 on May 18, 2017. (Id.
2
at ¶¶ 65, 68). Defendant SenesTech authorized the removal of the restriction from
3
Plaintiff’s remaining 281,011 shares by June 13, 2017. (Id. ¶ at 69). Plaintiff has since sold
4
most of its shares in Defendant SenesTech at prices “substantially below” the post-IPO
5
high and its acquisition costs. (Id. at ¶ 70).
6
II.
LEGAL STANDARD
7
To survive a Rule 12(b)(6) motion for failure to state a claim, a complaint must meet
8
the requirements of Rule 8(a)(2). Rule 8(a)(2) requires a “short and plain statement of the
9
claim showing that the pleader is entitled to relief,” so that the defendant has “fair notice
10
of what the . . . claim is and the grounds upon which it rests.” Bell Atl. Corp. v. Twombly,
11
550 U.S. 544, 555 (2007) (quoting Conley v. Gibson, 355 U.S. 41, 47 (1957)). A complaint
12
must also contain sufficient factual matter, which, if accepted as true, states a claim to relief
13
that is “plausible on its face.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009). Facial
14
plausibility exists if the pleader sets forth factual content that allows a court to draw the
15
reasonable inference that the defendant is liable for the misconduct alleged. Id. Plausibility
16
does not equal “probability,” but requires more than a sheer possibility that a defendant
17
acted unlawfully. Id. “Where a complaint pleads facts that are ‘merely consistent’ with a
18
defendant’s liability, it ‘stops short of the line between possibility and plausibility of
19
entitlement to relief.’” Id. (citing Twombly, 550 U.S. at 557).
20
Although a complaint attacked for failure to state a claim does not need detailed
21
factual allegations, the pleader’s obligation to provide the grounds for relief requires “more
22
than labels and conclusions, and a formulaic recitation of the elements of a cause of action
23
will not do.” Twombly, 550 U.S. at 555 (internal citations omitted). Rule 8(a)(2) “requires
24
a ‘showing,’ rather than a blanket assertion, of entitlement to relief,” as “[w]ithout some
25
factual allegation in the complaint, it is hard to see how a claimant could satisfy the
26
requirement of providing not only ‘fair notice’ of the nature of the claim, but also ‘grounds’
27
on which the claim rests.” Id. at 555 n.3 (citing 5 Charles A. Wright & Arthur R. Miller,
28
Federal Practice & Procedure § 1202, at 94–95 (3d ed. 2004)). Thus, Rule 8’s pleading
-6-
1
standard demands more than “an unadorned, the-defendant-unlawfully-harmed-me
2
accusation.” Iqbal, 556 U.S. at 678 (citing Twombly, 550 U.S. at 555).
3
For claims involving fraud, Rule 9(b) poses additional pleading requirements. Fed.
4
R. Civ. P. 9(b). Under Rule 9(b), a plaintiff alleging fraud “must state with particularity the
5
circumstances constituting fraud or mistake.” Id. “Averments of fraud must be
6
accompanied by ‘the who, what, when, where, and how’ of the misconduct charged.” Vess
7
v. Ciba-Geigy Corp. USA, 317 F.3d 1097, 1106 (9th Cir. 2003). Each and every element
8
of securities fraud must meet this heightened pleading standard. See Or. Pub. Emps. Ret.
9
Fund v. Apollo Gp. Inc., 774 F.3d 598, 605 (9th Cir. 2014). A complaint alleging securities
10
fraud is also subject to the Private Securities Litigation Reform Act (“PSLRA”). Under the
11
PSLRA, the complaint must “specify each statement alleged to have been misleading, the
12
reason or reasons why the statement is misleading, and, if an allegation regarding the
13
statement or omission is made on information and belief, the complaint shall state with
14
particularity all facts on which that belief is formed.” 15 U.S.C. § 78u–4(b)(1)(B) (2012).
15
In ruling on a Rule 12(b)(6) motion to dismiss, a court must construe the facts
16
alleged in the complaint in the light most favorable to the drafter and must accept all well-
17
pleaded factual allegations as true. See Shwarz v. United States, 234 F.3d 428, 435 (9th
18
Cir. 2000); see also Cafasso v. Gen. Dynamics C4 Sys., 637 F.3d 1047, 1053 (9th Cir.
19
2011). However, a court need not accept as true legal conclusions couched as factual
20
allegations. Papasan v. Allain, 478 U.S. 265, 286 (1986).
21
III.
ANALYSIS
22
Defendant SenesTech moves to dismiss Plaintiff’s fraud claims (Counts I–III) on
23
the grounds that Plaintiff fails to plead fraud with sufficient particularity in the FAC. (See
24
Doc. 71 at 11). Defendants also move to dismiss Plaintiff’s remaining claims on the
25
grounds that Plaintiff fails to plead facts that satisfy an essential element of each
26
outstanding claim in the FAC. (See id. at 20–23; Doc. 70 at 10–14).
27
A.
28
Plaintiff’s first claim against Defendant SenesTech alleges common law fraud.
Common Law Fraud (Count I)
-7-
1
(FAC at ¶¶ 71–77). Under Arizona law, a successful fraud claim requires proof of nine
2
elements:
3
6
(1) a representation; (2) its falsity; (3) its materiality; (4) the
speaker’s knowledge of its falsity or ignorance of its truth; (5)
the speaker’s intent that it be acted upon by the recipient in the
manner reasonably contemplated; (6) the hearer’s ignorance of
its falsity; (7) the hearer’s reliance on its truth; (8) the hearer’s
right to rely on it; (9) the hearer’s consequent and proximate
injury.
7
Comerica Bank v. Mahmoodi, 229 P.3d 1031, 1033–34 (Ariz. Ct. App. 2010) (citation
8
omitted).
4
5
9
Here, Plaintiff alleges Defendant SenesTech fraudulently induced Plaintiff to make
10
the April 2015 Loan and Late 2015 Loans, and to convert those loans into stock, by
11
affirmatively misrepresenting Defendant SenesTech’s corporate valuation and omitting
12
additional, material information. (FAC at ¶¶ 74–75). Specifically, Plaintiff alleges: (1)
13
Defendant SenesTech orally represented it “was worth approximately $55 to $60 million;”
14
(2) this representation was false in light of the omitted Redwood Valuation and 2015
15
Option Awards, which supported “a total corporate valuation of less than $2 million;” and
16
(3) the representations were material to Plaintiff’s decisions to offer loans to, and make
17
capital investments in, Defendant SenesTech. (Id. at ¶¶ 13, 22, 31). Plaintiff further alleges:
18
(4) Defendant SenesTech and its board of directors were “aware of the Redwood
19
Valuation” at all relevant times; (5) made the alleged misrepresentations in an effort to
20
secure funding from Plaintiff, which was based on the value of Defendant SenesTech’s
21
business; and (6) Plaintiff “was at all relevant times unaware of the Redwood Valuation
22
and the 2015 Option Awards[.]” (Id. at ¶¶ 23–24, 30–31). Plaintiff then alleges: (7) it made
23
its loans and investments “in reasonable reliance” on Defendant SenesTech’s valuation
24
misrepresentations; (8) it acted rightfully in relying on the valuation information provided
25
directly by Defendant SenesTech through its CEO; and (9) the misrepresentation
26
proximately caused Plaintiff financial loss by devoting capital to a company based on a
27
faulty valuation that it would otherwise not have invested in. (Id. at ¶¶ 18, 73–75). In
28
accepting all well-pleaded factual allegations as true, the Court finds that the FAC states a
-8-
1
2
claim for common law fraud. See Shwarz v. United States, 234 F.3d at 435.
1.
Rule 9(b)
3
Moreover, Rule 9(b) requires allegations of fraud to be “specific enough to give
4
defendants notice of the particular misconduct which is alleged to constitute the fraud
5
charged so that they can defend against the charge and not just deny that they have done
6
anything wrong.” Bly–Magee v. California, 236 F.3d 1014, 1019 (9th Cir. 2001). “While
7
statements of the time, place and nature of the alleged fraudulent activities are sufficient,
8
mere conclusory allegations of fraud are insufficient.” Moore v. Kayport Package Express,
9
Inc., 885 F.2d 531, 540 (9th Cir. 1989). In its previous Order (Doc. 57), the Court dismissed
10
Plaintiff’s first count because “Plaintiff [did] not specify the ‘who, what, when, where, and
11
how’ of the allegedly fraudulent misrepresentation.” (Doc. 57 at 7 (citing Vess v. Ciba-
12
Geigy Corp. USA, 317 F.3d 1097, 1106 (9th Cir. 2003))).
13
Here, Defendant SenesTech again contends “Plaintiff’s fraud-related claims . . . are
14
not plead with sufficient particularity.” (Doc. 71 at 11). The FAC states that Ziemba, as
15
Defendant SenesTech’s CEO, orally represented to Subramanian that Defendant
16
SenesTech “was worth approximately $55 to $60 million.” (FAC at ¶ 13–14). The
17
undisclosed Redwood Valuation, however, “placed the total value of [Defendant
18
SenesTech] at less than $2 million, and the individual shares at $0.06 each.” (FAC at ¶ 14).
19
The fraud allegation continues that Ziemba made this representation “at an in-person
20
meeting at an office park in Fremont, California” in March 2015.” (Id.). Plaintiff also
21
alleges Ziemba stated the “current value of [Defendant] SenesTech’s stock” was “$1.50
22
per share” at this meeting; such a price is consistent with the represented valuation, but
23
inconsistent with the Redwood Valuation. (Id.). Plaintiff further alleges that Ziemba
24
repeated the “$55 to $60 million” valuation assertion “at an in-person meeting in early to
25
mid-October 2015 in San Jose, California,” among other times. (Id. at ¶ 17). Finally,
26
Plaintiff explains Defendant SenesTech’s concealment of its corporate value proximately
27
caused Plaintiff’s financial losses when Defendant SenesTech’s true value “manifested
28
itself in a substantially lower-than-expected price at IPO and when [Plaintiff] was
-9-
1
permitted to sell its shares.” (Doc. 73 at 12; see also FAC at ¶ 70). Accordingly, the Court
2
finds that Plaintiff specifies the “who, what, when, where, and how” of Defendant
3
SenesTech’s allegedly fraudulent misrepresentations required to plead its claims with
4
sufficient particularity in the FAC. See Vess, 317 F.3d at 1106; Moore, 885 F.2d at 540.2
5
Thus, Defendant SenesTech’s motion to dismiss is denied as to Plaintiff’s common law
6
fraud claim (Count I).
7
B.
8
Next, Plaintiff asserts claims for securities fraud under federal (Count II) and state
9
(Count
Securities Fraud (Counts II–III)
III)
law
stemming
from Defendant
SenesTech’s
alleged affirmative
10
misrepresentation of its corporate value and failure to disclose the Redwood Valuation and
11
2015 Option Awards. (FAC at ¶¶ 81, 88). Section 10(b) of the Securities Exchange Act, 15
12
U.S.C. § 78j(b) (2012), and SEC Rule 10b-5 promulgated thereunder, 17 C.F.R. § 240.10b-
13
5 (2016), prohibit fraudulent activities in connection with securities transactions.
14
Specifically, Section 10(b) makes it unlawful:
15
17
[t]o use or employ, in connection with the purchase or sale of
any security . . . , any manipulative or deceptive device or
contrivance in contravention of such rules and regulations as
the [SEC] may prescribe as necessary or appropriate in the
public interest or for the protection of investors.
18
15 U.S.C. § 78j(b). Rule 10b-5 describes certain types of behavior proscribed by the
19
statute, including:
16
20
mak[ing] any untrue statement of a material fact or [omitting]
a material fact necessary in order to make the statements made,
in the light of the circumstances under which they were made,
not misleading.
21
22
23
17 C.F.R. § 240.10b-5(b).
24
A plaintiff asserting a securities fraud claim under Rule 10b-5 must adequately
25
allege six elements: “(1) a material misrepresentation or omission by the defendants;
26
27
28
2
To the extent Defendant SenesTech challenges other specific elements of
Plaintiff’s common law fraud claim, the Court will address those arguments in the context
of Plaintiff’s securities fraud claims because the claims stem from the same underlying
conduct, and Defendant SenesTech conflates its common law fraud and securities fraud
arguments in its motion to dismiss. (See Doc. 71 at 15–19); see also infra Part III(B).
- 10 -
1
(2) scienter; (3) a connection between the misrepresentation or omission and the purchase
2
or sale of a security; (4) reliance upon the misrepresentation or omission; (5) economic
3
loss; and (6) loss causation.” Lloyd v. CVB Fin. Corp., 811 F.3d 1200, 1206 (9th Cir. 2016)
4
(quoting Erica P. John Fund, Inc. v. Halliburton Co., 563 U.S. 804 (2011)). Moreover, a
5
plaintiff must satisfy the significantly heightened pleading requirements of Rule 9(b) and
6
the PSLRA. 15 U.S.C. § 78u; see supra Part II. In particular, a complaint alleging that a
7
defendant made misleading statements must: “(1) ‘specify each statement alleged to have
8
been misleading [and] the reason or reasons why the statement is misleading,’
9
15 U.S.C. § 78u–4(b)(1); and (2) ‘state with particularity facts giving rise to a strong
10
inference that the defendant acted with the required state of mind,’ [id.] § 78u–4(b)(2).”
11
Tellabs, Inc. v. Makor Issues & Rights, Ltd., 551 U.S. 308, 321 (2007).
12
The elements of a securities fraud claim under the Arizona Securities Act, Arizona
13
Revised Statute § 44-1991(A), are “almost identical” to its federal counterpart. Ariz. Rev.
14
Stat. § 44-1991(A)(2) (stating that it is a fraud to “[m]ake any untrue statement of material
15
fact, or omit to state any material fact necessary in order to make the statements made, in
16
the light of the circumstances under which they were made, not misleading”); Grand v.
17
Nacchio, 236 P.3d 398, 400 (2010) (equating the federal and state law elements).
18
Accordingly, the Court will analyze the state and federal securities fraud claims
19
simultaneously. Here, Defendant SenesTech argues Plaintiff’s securities fraud claims are
20
not pleaded with particularity, do not meet the pleading requirements for each element, and
21
the affirmative securities fraud claims are time-barred. (See Doc. 71 at 13–19).
22
1.
Rule 9(b) and the PSLRA
23
Preliminarily, Defendant SenesTech contends Plaintiff failed to plead its claims
24
with particularity as required by Rule 9(b) and the PSLRA. (See id. at 13). As reasoned
25
above, the Court finds that Plaintiff specifies that “who, what, when, where, and how” of
26
Defendant SenesTech’s allegedly fraudulent misrepresentations
27
particularity in the FAC. See supra Part III(A)(1) (citing Vess, 317 F.3d at 1106).
28
Moreover, Plaintiff details the precise statements “alleged to have been misleading” in the
- 11 -
with sufficient
1
FAC, as required by the PSLRA; namely, that “[Defendant] SenesTech was worth
2
approximately $55 to $60 million.” (See FAC at ¶ 13); see also 15 U.S.C. § 78u–4. Plaintiff
3
further explains that Defendant SenesTech’s representation of its corporate valuation at
4
“$55 to $60 million” is misleading because the Redwood Valuation and 2015 Option
5
Awards—which Plaintiff alleges Defendant SenesTech knew of and concealed from
6
Plaintiff at all relevant times—support a much lower valuation “at less than $2 million.”
7
(Id. at ¶¶ 22, 31). Accordingly, the Court finds that Plaintiff’s securities fraud allegations
8
also meet the heightened pleading requirements of the PSLRA.
9
2.
Timeliness
10
Next, Defendant SenesTech argues Plaintiff’s affirmative securities fraud claims are
11
time-barred. (See Doc. 71 at 13). A complaint filed in a private3 securities fraud action “is
12
timely if filed no more than two years after a plaintiff ‘discover[ed] the facts constituting
13
the violation.’” Merck & Co., Inc. v. Reynolds, 559 U.S. 633, 637 (2010) (quoting 28
14
U.S.C. § 1658(b)(1) (alterations in original)). Moreover, a cause of action accrues: “(1)
15
when the plaintiff did in fact discover, or (2) when a reasonably diligent plaintiff would
16
have discovered, the facts constituting the violation—whichever comes first.” Id. (internal
17
quotation marks omitted); see also Maverick Fund, L.D.C. v. First Solar, Inc., No. CV-15-
18
1156-PHX-DGC, 2018 WL 6181241, at *15 (D. Ariz. Nov. 27, 2018) (applying the same
19
two-year rule for securities fraud claims brought under state law in Arizona).
20
Here, Defendant SenesTech states that Plaintiff’s allegations of affirmative fraud
21
were first disclosed in the then-proposed FAC on January 25, 2019. (Doc. 71 at 14). Thus,
22
a reasonably diligent plaintiff must have discovered the facts of the alleged, affirmative
23
misrepresentations after January 25, 2017 to maintain a timely claim. (See id.). Defendant
24
SenesTech argues that “[a]ny reasonably diligent investor would have discovered the
25
alleged fraud before January 25, 2017 because, in advance of its IPO, [Defendant]
26
SenesTech publicly filed with the SEC a Form S-1 (dated September 21, 2016) and a
27
28
3
It is undisputed that Defendant SenesTech was a private company at the time of
its allegedly fraudulent misrepresentations prior to its IPO. (See Doc. 71 at 13; Doc. 73 at
11).
- 12 -
1
Prospectus (dated December 8, 2016).” (Id.). The argument follows that those SEC filings
2
demonstrate that Defendant SenesTech “was not [worth] approximately $55 to $60
3
million” at that time. (Id. (internal quotation marks and citations omitted)). Defendant
4
SenesTech, however, does not point to any specific statements regarding valuation in those
5
SEC filings, or any clarifications elsewhere in the record demonstrating that it corrected its
6
alleged valuation misrepresentation or disclosed the Redwood Valuation prior to January
7
25, 2017. (Compare id. at 14–15, with Doc. 73 at 13).
8
Defendant SenesTech continues that a reasonable investor would have understood
9
the valuation of the company to be below “$55 to $60 million” from the “extensive amount
10
of financial information disclosed” in the SEC filings. (Doc. 71 at 14). Defendant
11
SenesTech again does not identify any specific financial information that would require
12
such a conclusion. (See id.). Moreover, “[t]he question of whether the plaintiff exercised
13
reasonable diligence in investigating the facts underlying the alleged fraud . . . necessarily
14
entails an assessment of the plaintiff’s particular circumstances from the perspective of a
15
reasonable investor.” Alameda v. Nuveen Mun. High Income Opportunity Fund, No. CV-
16
08-3137 SI, 2009 WL 1424529, at *8 (N.D. Cal. May 20, 2009) (quoting In re American
17
Funds Sec. Litig., 556 F.Supp.2d 1100, 1105 (C.D. Cal. 2008)). Such an inquiry is “a
18
factual matter that is not appropriate for consideration on the pleadings.” Id. Accordingly,
19
the Court finds that “arguments about timeliness are premature and cannot be resolved” at
20
the motion to dismiss stage. Id.
21
3.
Materiality and Falsity
22
Next, Defendant SenesTech argues that Plaintiff fails to adequately plead the
23
elements of securities fraud; the first of which requires a material misrepresentation. (Doc.
24
71 at 11–19). Materiality is satisfied when there is “a substantial likelihood that the
25
disclosure of the [truth] would have been viewed by the reasonable investor as having
26
significantly altered the ‘total mix’ of information made available.” Matrixx Initiatives,
27
Inc. v. Siracusano, 563 U.S. 27, 38 (2011) (citation and internal quotation marks omitted);
28
see also Hirsch v. Ariz. Corp. Comm’n, 352 P.3d 925, 932–33 (Ariz. Ct. App. 2015) (“The
- 13 -
1
requirement of materiality is satisfied by a showing of substantial likelihood that, under all
2
the circumstances, the misstated or omitted fact would have assumed actual significance in
3
the deliberations of a reasonable buyer” (internal quotation marks and citation omitted)).
4
“Under this test, there is no need to investigate whether an omission or misstatement was
5
actually significant to a particular buyer.” Hirsch, 352 P.3d at 933.
6
In its previous Order (Doc. 57), the Court dismissed Plaintiff’s securities fraud
7
claims because the OC only alluded to vague “statements regarding the valuation of and
8
risk associated with its securities.” (Doc. 57 at 11 (citations omitted)). In the OC, Plaintiff
9
“fail[ed] to point to any affirmative statements made by Defendant SenesTech that became
10
misleading” based on undisclosed valuation information. (Id.). The FAC, however, cures
11
this defect by identifying specific statements by Defendant SenesTech, made through
12
Ziemba as its CEO, stating that the company “was worth approximately $55 to $60
13
million.” (FAC at ¶ 13). A represented valuation of “$55 to $60 million” undoubtedly
14
creates “an impression of a state of affairs that differs in a material way from the one that
15
actually exists” if the Defendant SenesTech was valued at “less than $2 million,” as pleaded
16
based on the Redwood Valuation and basis for the 2015 Option Awards. (See id. at ¶¶ 22,
17
31); see also Lloyd, 811 F.3d at 1209. Accordingly, the Court finds that Plaintiff adequately
18
pleaded facts satisfying the element of a material misrepresentation in the FAC.
19
4.
Scienter
20
To state a securities fraud claim, Plaintiff must also plead facts satisfying the
21
element of scienter. “Knowing or intentional conduct satisfies the required state of mind”
22
to find scienter in a securities fraud action. In re Countrywide Fin. Corp. Sec. Litig., 588
23
F. Supp. 2d 1132, 1185–86 (C.D. Cal. 2008) (quoting S. Ferry LP, No. 2 v. Killinger, 542
24
F.3d 776, 782 (9th Cir. 2008) (internal quotation marks and alterations omitted)).
25
“Deliberate recklessness, which is recklessness that reflects some degree of intentional or
26
conscious misconduct” also establishes scienter under Ninth Circuit law. Id. (internal
27
quotation marks and citations omitted).
28
Here, Plaintiff pleaded that Defendant SenesTech and its board of directors were
- 14 -
1
aware of the Redwood Valuation and 2015 Option Awards “at all relevant times,” but
2
“purposefully concealed” this material information from Plaintiff. (FAC at ¶¶ 30, 75, 81).
3
Significantly inflating an estimate of a corporate valuation and concealing contradictory
4
valuation information permits a “cogent and compelling” inference of scienter. See Tellabs,
5
Inc. v. Makor Issues & Rights, Ltd., 551 U.S. 308, 310 (2007). Accordingly, the Court finds
6
that Plaintiff adequately pleaded facts satisfying the element of scienter in the FAC.
7
5.
Connection
8
Next, a securities fraud claim requires “a connection between the misrepresentation
9
or omission and the purchase or sale of a security.” Lloyd v. CVB Fin. Corp., 811 F.3d
10
1200, 1206 (9th Cir. 2016) (citation omitted). Here, Plaintiff alleges Ziemba, Defendant
11
SenesTech’s then-CEO, misrepresented the corporate valuation of Defendant SenesTech
12
in negotiations with Plaintiff for loans and investments in Defendant SenesTech. (FAC at
13
¶ 12). The omission of the Redwood Valuation and 2015 Option Awards allegedly
14
continued through several rounds of financing and the conversion of loans into stock in
15
Defendant SenesTech. (Id. ¶ 16). Accordingly, the Court finds that Plaintiff adequately
16
pleaded facts connecting the alleged misrepresentation with the sale and purchase of
17
securities—namely, stock in Defendant SenesTech.
18
6.
Reliance
19
Next, a plaintiff must allege it “reasonably relied” on an allegedly fraudulent
20
misrepresentation. See, e.g., Cooper v. Thoratec Corp., No. 14-cv-0360 CW, 2018 WL
21
2117337, at *3 (N.D. Cal. May 8, 2018) (“In order to bring a claim under Section 10(b),
22
the plaintiff must show individual reliance on a material misstatement” (internal quotation
23
marks and citation omitted)). In the FAC, Plaintiff explains it relied on Defendant
24
SenesTech’s valuation representations—specifically made through Ziemba, as Defendant
25
SenesTech’s CEO—in converting the April 2015 Loan and Late 2015 Loans into stock.
26
(FAC at ¶¶ 74, 82). The Court finds that, as pleaded, Plaintiff was reasonable in relying on
27
a CEO’s allegedly material misrepresentations about his own company’s valuation in
28
making investment decisions. See, e.g., Trinity Indus. Leasing Co. v. Midwest Gas Storage,
- 15 -
1
Inc., 33 F. Supp. 3d 947, 971 (N.D. Ill. 2014) (reasoning that a plaintiff “adequately alleged
2
justifiable reliance on fraudulent representations” when relying on statements made by the
3
defendant’s CEO about the defendant’s own financial condition). Accordingly, the Court
4
finds that Plaintiff adequately pleaded facts satisfying the element of reliance.
5
7.
Economic Loss and Loss Causation
6
Finally, a plaintiff must plead economic loss and loss causation to state a securities
7
fraud claim. See Lloyd, 811 F.3d at 1206. Preliminarily, the Court observes that Plaintiff
8
pleaded economic loss in alleging that it would not have made the capital investments in
9
Defendant SenesTech but for Defendant SenesTech’s alleged misrepresentations, which
10
resulted in Plaintiff selling its stock in Defendant SenesTech “at a loss.” (FAC at ¶¶ 83,
11
90). Moreover, Defendant SenesTech does not challenge that Plaintiff adequately pleaded
12
economic loss, but rather focuses its arguments on causation. (See Doc. 71 at 11–13).
13
“It is unclear in this Circuit whether Rule 9(b)’s heightened pleading standard or
14
whether Rule 8(a)(2)’s short and plain statement applies to allegations of loss causation.”
15
Sierp v. DeGreen Partners LP, No. CV-16-00189-PHX-GMS, 2017 WL 67531, at *12 (D.
16
Ariz. Jan. 6, 2017) (citation omitted); but see Mandalevy v. Bofi Holding, Inc., No. CV-17-
17
667-GPC-KSC, 2018 WL 6436723, at *4 (S.D. Cal. Dec. 7, 2018) (“In the Ninth Circuit,
18
Rule 9(b)’s heightened pleading standard applies to all elements of a securities fraud claim,
19
including loss causation” (citation omitted)). Regardless, “[t]he pleading requirements for
20
loss causation are not stringent standards.” Sierp, 2017 WL 67531, at *11. “[I]f a plaintiff
21
shows the misrepresentations affected the financial health of an entity and, consequently,
22
the value of the plaintiff’s stock, the plaintiff has made a sufficient showing of proximate
23
cause.” Id. (citation omitted) (emphasis added).
24
Here, Plaintiff’s theory of loss causation is precisely that; as pleaded, Defendant
25
SenesTech’s alleged misrepresentations were about the value of the company and,
26
consequently, the value of its stock. See id. (explaining that a fraud complaint is satisfactory
27
at this stage in the pleadings if it simply “offers sufficient detail to give defendants ample
28
notice of [the] loss causation theory, and [gives] some assurance that the theory has a basis
- 16 -
1
in fact” (citation omitted) (alterations in original)). Accordingly, the Court finds that
2
Plaintiff
3
misrepresentations proximately caused Plaintiff’s losses at this early stage in the pleadings.
4
Thus, the Court finds that Plaintiff adequately pleaded each element of its securities
5
fraud claims in the FAC. Defendant SenesTech’s motion to dismiss is denied as to
6
Plaintiff’s federal and state securities fraud claims (Count II–III).
adequately
pleaded—under
either
standard—Defendant
SenesTech’s
7
C.
8
Next, Plaintiff alleges a violation of 6 Delaware Code § 8-401 against Defendant
9
SenesTech. (FAC at ¶¶ 92–101). The relevant code provision provides that “[i]f a
10
certificated security in registered form is presented to an issuer with a request to register
11
transfer . . . the issuer shall register the transfer as requested,” as long as certain
12
preconditions are met. Del. Code Ann. tit. 6, § 8-401(a).4 “Presenting the certificated
13
security is not a technicality” if the security is indeed certificated. Jing Jing v. Weyland
14
Tech, Inc., No. CV 17-446, 2017 WL 2618753, at *3 (D. Del. June 15, 2017). The relevant
15
code provision also provides that the same registration requirement applies if “an
16
instruction is presented to an issuer with a request to register transfer of an uncertificated
17
security” and other preconditions are met. Del. Code Ann. tit. 6, § 8-401(a).5 “If an issuer
18
is under a duty to register a transfer of a security, the issuer is liable to a person presenting
19
. . . an instruction for registration . . . for loss resulting from unreasonable delay in
20
registration or failure or refusal to register the transfer.” Id. at § 8-401(b).
Violation of Delaware Code § 8-401 (Count IV)
21
In its previous Order (Doc. 57), the Court dismissed this claim because “Plaintiff
22
[did] not plead that it ever presented the certificates to Defendant SenesTech,” nor did
23
Plaintiff plead that the stock was uncertificated in the OC. (Doc. 57 at 13); see also Jing
24
Jing, 2017 WL 2618753, at *3. As pleaded in the FAC, Plaintiff clarifies that all stock in
25
Defendant SenesTech owned by Plaintiff was “maintained in uncertificated ‘book entry’
26
A “certificated security” is “a security that is represented by a certificate.” Del.
Code Ann. tit. 6, § 8-102(4).
27
4
An “uncertificated security” is a security that is not represented by a certificate.
Del. Code Ann. tit. 6, § 8-102(18).
5
28
- 17 -
1
form, such that no physical stock certificates exist.” (FAC at ¶ 42). Because the FAC states
2
that the securities were uncertificated, “presentation was de facto accomplished at all
3
times.” (Doc. 57 at 13).
4
Moreover, the Court observed in its previous Order (Doc. 57) that Plaintiff then-
5
alleged “making a proper request to register transfer through [its] opinion letter.” (Id. at 14
6
(alteration in original)). Defendant SenesTech acknowledges that it had a duty to register
7
the transfer as requested if “[Defendant] SenesTech received a satisfactory opinion of
8
counsel stating that such registration is not required for sale or transfer.” (Doc. 71 at 21
9
(citation omitted)). Plaintiff alleges its counsel provided the satisfactory November
10
Opinion Letter to Defendant SenesTech on November 7, 2016; thus requesting removal of
11
the restriction that inhibited Plaintiff from selling its shares immediately following
12
Defendant SenesTech’s IPO. (FAC at ¶¶ 48–49, 95). As pleaded, however, Defendant
13
SenesTech did not remove the restriction and register the transfer until June 2017, thus
14
constituting unreasonable delay and forcing Plaintiff to sell its shares in Defendant
15
SenesTech at a lower stock price than available shortly after the IPO. (Id. at ¶¶ 99–100).
16
Additionally, Plaintiff adds in the FAC that Defendant SenesTech “should have
17
found the opinion letter to be a satisfactory opinion of counsel”—thus triggering Defendant
18
SenesTech’s duty to register the transfer—because it provides an accurate statement of
19
Plaintiff’s ability to sell or transfer its stock without registration. (See FAC at ¶¶ 95–96).6
20
Plaintiff specifically pleaded that it satisfied all other preconditions of 6 Delaware Code §
21
8-401 in the FAC. (See FAC at ¶ 97(a)–(g)). By stating in the FAC that the securities held
22
by Plaintiff were uncertificated, Plaintiff has now pleaded the essential element that was
23
fatal to its claim in the OC. (See FAC at ¶¶ 42, 96). Accordingly, the Court finds that
24
Plaintiff adequately pleaded its claim for a violation of 6 Delaware Code § 8-401. Thus,
25
Defendant SenesTech’s motion to dismiss is denied as to Plaintiff’s claim for a violation
26
While Defendant SenesTech argues that Plaintiff’s request was not rightful based
on differing understandings of when an unregistered transfer is allowable, this contention
appears to create a dispute of fact regarding the reasons belying unregistered transfer,
which the Court need not resolve at this stage in the pleadings. (Compare Doc. 71 at 22–
23, with Doc. 73 at 16–17).
27
28
6
- 18 -
1
of 6 Delaware Code § 8-401 (Count IV).
2
D.
Remaining Claims against Defendant SenesTech (Counts V–VII)
3
Plaintiff also alleges claims for breach of contract (Count V), tortious interference
4
(Count VI), and conversion (Count VII) against Defendant SenesTech. (See Doc. 71 at
5
23).7 As Defendant SenesTech acknowledges, “if Count IV fails, so must Counts V, VI,
6
and VII” because the remaining claims are all premised on Count IV. (Id.). In denying
7
Defendant SenesTech’s motion to dismiss as to Count IV, however, it stands to reason that
8
Plaintiff’s remaining claims against Defendant SenesTech likewise survive. (See Doc. 57
9
at 14–16). Moreover, Defendant SenesTech makes no independent arguments about the
10
viability of any of Plaintiff’s remaining claims. (See Doc. 71 at 23). Accordingly,
11
Defendant SenesTech’s motion to dismiss is denied as to Plaintiff’s remaining claims
12
against it. (Counts V–VII).
13
E.
14
Defendant Roth joins Defendant SenesTech’s Motion to Dismiss (Doc. 71) pursuant
15
to Rules 8(a), 9(b), and 12(b)(6) and separately argues that each of Plaintiff’s three
16
outstanding claims against it should be dismissed. (Doc. 70 at 2).
17
Claims against Defendant Roth (Counts VI–VIII)
1.
Tortious Interference (Count VI)
18
Plaintiff asserts a claim for tortious interference with a business expectancy against
19
both Defendants. (FAC at ¶¶ 112–120). In order to state a claim for tortious interference
20
under Arizona law, a plaintiff must allege: “(1) the existence of a valid business
21
expectancy; (2) the interferer’s knowledge of the business expectancy; (3) the interferer
22
intentionally induced or caused termination of the business expectancy; and (4) damage
23
suffered as a result of termination of the business expectancy.” Dube v. Likins, 167 P.3d
24
93, 99 (Ariz. Ct. App. 2007). Further, Arizona law recognizes that “one is subject to
25
liability if he . . . does a tortious act in concert with [another] or pursuant to a common
26
design with him.” Id. at 100 (internal quotation marks and citations omitted).
27
The Court notes that Plaintiff’s claims for tortious interference (Count VI) and
conversion (Count VII) are also brought against Defendant Roth. (See FAC at ¶¶ 112–126).
The Court will separately analyze those claims with respect to Defendant Roth.
28
7
- 19 -
1
Here, Plaintiff alleges: (1) Plaintiff had a valid business expectancy that it would be
2
able to sell its shares of Defendant SenesTech—upon removal of the restriction—based on
3
the market for shares created by Defendant SenesTech’s IPO on December 8, 2017; (2)
4
Plaintiff communicated this business expectancy to both Defendants, including to a
5
managing director of Defendant Roth in November 2017; (3) Defendant Roth wrongfully
6
instructed Defendant SenesTech to withhold permission from its transfer agent to remove
7
the restriction from Plaintiff’s shares, which prohibited Plaintiff from selling its shares for
8
months after the IPO; and (4) this delay caused Plaintiff to be unable to sell its 859,133
9
shares in Defendant SenesTech at a higher price than it ultimately received. (FAC at ¶¶ 51,
10
114–118). In accepting all well-pleaded factual allegations as true, the Court finds that the
11
FAC states a claim for tortious interference with a business expectancy against Defendant
12
Roth.
13
In its previous Order (Doc. 57), the Court dismissed this claim because Plaintiff
14
failed to adequately plead that Defendant SenesTech’s refusal to instruct its transfer agent
15
to remove the restriction from Plaintiff’s shares was wrongful under Delaware law (Count
16
IV). The Court finds herein that the FAC adequately states a claim for a violation of
17
Delaware law; thus upholding the premise of Plaintiff’s claim for tortious interference and
18
establishing the existence of a valid business expectancy. See supra Part III(C). Defendant
19
Roth specifically argues that Plaintiff cannot satisfy element (3)—that Defendant Roth is
20
responsible for interfering with Plaintiff’s business expectancy—because the FAC “does
21
not allege any affirmative act of interference by [Defendant] Roth.” (Doc. 70 at 10).
22
Plaintiff does, however, allege Defendant SenesTech’s reasoning for refusing to instruct
23
its transfer agent to remove the restriction from Plaintiff’s shares was that “[Defendant]
24
Roth has said they will not permit any delegending of shares at this late stage in the [IPO]
25
process.” (FAC at ¶ 51). Moreover, the fact that Defendant SenesTech ceded to Defendant
26
Roth’s instruction, which prohibited Plaintiff from selling any of its shares for months after
27
the IPO, demonstrates “that [Defendant] SenesTech recognized the legitimacy of
28
[Defendant] Roth’s command.” (See Doc. 72 at 9). Accordingly the Court finds that, as
- 20 -
1
pleaded, Defendant Roth terminated Plaintiff’s valid business expectancy by influencing
2
Defendant SenesTech to wrongfully restrict Plaintiff from selling its shares in a timely
3
manner. See Dube, 167 P.3d at 100. Thus, Defendant Roth’s motion to dismiss is denied
4
as to Plaintiff’s claim for tortious interference with a business expectancy (Count VI).
5
2.
Conversion (Count VII)
6
Next, Plaintiff asserts a claim for conversion against both Defendants. (FAC at ¶¶
7
121–126). Conversion under Arizona law is “the act of wrongful dominion or control over
8
personal property in denial of or inconsistent with the rights of another.” Case Corp. v.
9
Gehrke, 91 P.3d 362, 365 (Ariz. Ct. App. 2004) (citation omitted).
10
Here, Plaintiff’s conversion claim is similarly based on the allegation that
11
Defendants converted Plaintiff’s stock by “intentionally and unreasonably delay[ing] in
12
instructing its transfer agent to remove the restriction.” (FAC at ¶ 123). Plaintiff again
13
alleges that Defendant SenesTech withheld permission to remove the restriction at
14
Defendant Roth’s behest. (Id.). Again, the Court dismissed this claim in its previous Order
15
(Doc. 57) because it was based on the then-unestablished premise that Defendant
16
SenesTech’s refusal to instruct the transfer agent to remove the restriction was wrongful
17
under Delaware law (Count IV). (See Doc. 57 at 16). Consistent with the above reasoning,
18
Plaintiff adequately pleaded the claim under Delaware law, upon which its conversion
19
claim is based in the FAC. See supra Part III(C).
20
Additionally, Defendant Roth argues that the FAC does not allege Defendant Roth
21
“exercised wrongful dominion” over Plaintiff’s shares. (Doc. 70 at 13). Consistent with the
22
above reasoning, however, Plaintiff pleaded that Defendant Roth exercised dominion over
23
Plaintiff’s shares “by virtue of its ability to [successfully] command [Defendant]
24
SenesTech not to [remove the restriction from] the shares.” (Doc. 72 at 11); see supra Part
25
III(E)(1). Moreover, this exercise of dominion is wrongful if Defendant SenesTech’s
26
refusal to instruct its transfer agent to remove the restriction violates 6 Delaware Code § 8-
27
401, as pleaded. See Jing Jing, 2017 WL 2618753, at *5 (implying that “Defendants’
28
refusal to remove the restrictive legend can be construed as an act of dominion over
- 21 -
1
[Plaintiff’s] shares”—thus establishing a claim for conversion—if it is “a wrongful act”
2
that violates 6 Delaware Code § 8-401). Accordingly, the Court finds that Plaintiff
3
adequately pleaded a claim for conversion.8 Thus, Defendant Roth’s motion to dismiss is
4
denied as to Plaintiff’s claim for conversion (Count VII).
5
3.
Breach of Contract (Count VIII)
6
Finally, Plaintiff asserts a claim for breach of contract against Defendant Roth
7
related to the Lock-Up Agreement. (FAC at ¶¶ 127–139). The Lock-Up Agreement states
8
that it “shall be governed” by California law. (Doc. 15-1 at 4). Under California law, “[t]he
9
standard elements of a claim for breach of contract are: (1) the contract, (2) plaintiff’s
10
performance or excuse for nonperformance, (3) defendant’s breach, and (4) damage to
11
plaintiff therefrom.” Wall Street Network, Ltd. v. N. Y. Times Co., 80 Cal. Rptr. 3d 6, 12
12
(Cal. Ct. App. 2008); see also Cal. Civ. Code § 1550.
13
Here, Plaintiff alleges that Defendant Roth breached the Lock-Up Agreement by
14
refusing “to authorize [Defendant] SenesTech to remove the restriction on sale for the
15
50,000 shares” exempted by the Lock-Up Agreement; thus prohibiting Plaintiff from
16
selling any of its shares until months after the IPO. (FAC at ¶ 137). In its previous Order
17
(Doc. 57), the Court dismissed this claim against Defendant Roth because Plaintiff did not
18
plead the element of breach without alleging “when, how, or if Plaintiff ever sought . . .
19
permission from Defendant Roth” to remove the restriction on Plaintiff’s shares. (Doc. 57
20
at 17). The FAC, however, now alleges that Plaintiff—through Subramanian as its agent—
21
contacted a managing director for Defendant Roth to request “removal of the restriction on
22
sale for the 50,000 post-reverse-split shares that had been carved out of the Lock-Up
23
Agreement,” which Defendant Roth previously “committed” to authorize. (FAC at ¶¶ 131,
24
133).
25
While Defendant Roth mentions that Plaintiff’s conversion claim is barred by the
economic loss rule to the extent it is tied to Plaintiff’s final breach of contract claim,
Plaintiff rather tethers its conversion claim to the same reasoning supporting its tortious
interference claim. (See Doc. 70 at 13). Additionally, Defendant Roth provides no citation
nor explanation for how the economic loss rule operates to bar the conversion claim, so the
Court will not grant dismissal based on that argument at this time.
8
26
27
28
- 22 -
1
As Defendant Roth points out, the OC also “failed to specify whether [Defendant]
2
Roth had sole authority to allow Plaintiff to sell the exempted shares without the additional
3
authorization of [Defendant] SenesTech.” (Doc. 70 at 14 (citing Doc. 57 at 18)). The FAC
4
further clarifies that, as pleaded, Defendant Roth “had actual authority to instruct
5
[Defendant SenesTech] with respect to removal of the restriction on sale.” (FAC at ¶ 135);
6
see supra Part III(E)(1). While Defendant Roth argues that this allegation is conclusory, as
7
pleaded, Defendant SenesTech confirmed in an SEC filing that Defendant Roth had the
8
sole authority to remove the restriction from Plaintiff’s shares. (FAC at ¶ 136).9 Having
9
resolved the issues the Court identified in its previous Order (Doc. 57) with respect to this
10
claim, the Court finds that the FAC adequately alleges the element of breach. Plaintiff
11
further alleges—and Defendant Roth does not dispute—the remaining elements for a
12
breach of contract claim; namely, that Plaintiff “performed all of its obligations under the
13
[Lock-Up Agreement]” and suffered financial injury by having to wait until months after
14
the IPO to sell its exempted shares at a lower share price. (FAC at ¶¶ 137–139).
15
Accordingly, Defendant Roth’s motion to dismiss is denied as to Plaintiff’s claim for
16
breach of contract (Count VIII).
17
IV.
CONCLUSION
IT IS ORDERED that Defendant SenesTech, Inc.’s Motion to Dismiss (Doc. 71)
18
19
is DENIED.
20
///
21
///
22
///
23
///
24
///
25
///
26
Defendant SenesTech’s Form S-1 filed with the SEC in advance of its IPO states
that “[Defendant Roth] may, in its sole discretion, at any time or from time to time and
without notice, release for sale in the public market all or any portion of the shares restricted
by the terms of the lock-up agreements.” (FAC at ¶ 136 (emphasis added)).
9
27
28
- 23 -
1
IT IS FURTHER ORDERED that Defendant Roth Capital Partners, LLC’s
2
Motion to Dismiss (Doc. 70) is DENIED. The Clerk of the Court shall not enter judgment
3
at this time.
4
Dated this 16th day of August, 2019.
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
- 24 -
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?